Institut für klinische Radiologie, Universitätsklinik Grosshadern, LMU München, München, Germany.
Dtsch Arztebl Int. 2010 Jun;107(22):383-9. doi: 10.3238/arztebl.2010.0383. Epub 2010 Jun 4.
Whole-body magnetic resonance imaging (WB-MRI) is a modern imaging method, free of ionizing radiation, which provides high-resolution display of individual organ systems and of the anatomy of the entire body.
Selective literature review
Multi-channel WB-MRI scanners enable both the high-resolution imaging of the entire body and focused studies of individual organs, through the use of various sequence techniques and contrast modes. The initial application of combined cardiovascular and oncological imaging protocols for the screening of asymptomatic persons has already revealed many cases of cardiovascular disease and of tumors with serious clinical implications. The diagnostic accuracy of M staging with WB-MRI lies in the range of 93% to 97%. WB-MRI provides good contrast of the bone marrow, and has thus been used for the diagnosis of malignant bone marrow disease as well: in particular, it is especially sensitive for multiple myeloma and plays an important role in prognostication and therapeutic decision-making in this disorder. To date, WB-MRI has not been shown to be superior to other diagnostic techniques with respect to hard endpoints, such as prolongation of survival. It also carries the risk of false positive findings.
Despite these encouraging results, undirected screening by WB-MRI without an appropriate indication, as is currently being practiced in many institutions, is decidedly inadvisable in view of its predicted diagnostic yield below 2% and the lack of evidence for its cost-effectiveness.
全身磁共振成像(WB-MRI)是一种无电离辐射的现代成像方法,它提供了个体器官系统和整个身体解剖结构的高分辨率显示。
选择性文献回顾
多通道 WB-MRI 扫描仪通过使用各种序列技术和对比模式,能够实现全身的高分辨率成像和对单个器官的重点研究。联合心血管和肿瘤成像方案的最初应用已经为无症状者的筛查发现了许多具有严重临床意义的心血管疾病和肿瘤病例。WB-MRI 用于 M 分期的诊断准确性在 93%到 97%之间。WB-MRI 对骨髓有很好的对比度,因此也用于恶性骨髓疾病的诊断:特别是对多发性骨髓瘤尤其敏感,并在该疾病的预后和治疗决策中发挥重要作用。迄今为止,WB-MRI 在硬终点方面(如生存时间延长)并未显示优于其他诊断技术。它还存在假阳性发现的风险。
尽管有这些令人鼓舞的结果,但鉴于其预测的诊断收益低于 2%,并且缺乏成本效益的证据,目前许多机构正在进行的无适当适应证的 WB-MRI 定向筛查显然是不可取的。